Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “BRAINSTORM CELL THERAPEUTICS LTD.”

8 pharma patents match "BRAINSTORM CELL THERAPEUTICS LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 8
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 8 pharmaceutical patents matching "BRAINSTORM CELL THERAPEUTICS LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

8 results for “BRAINSTORM CELL THERAPEUTICS LTD.” · 30,257 patents in full index Clear search

  1. US 12233092

    MSC-NTF specific exosomes and use thereof

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 11185572

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Nov 30, 2021 · Expires Nov 25, 2041

    granted
  3. US 10564149

    Populations of mesenchymal stem cells that secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  4. US 10052363

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted
  5. US 10046010

    Methods of generating mesenchymal stem cells which secrete neurotrophic factors

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted
  6. US 9474787

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted
  7. US 8900574

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Dec 2, 2014 · Expires Nov 27, 2034

    granted
  8. US 8663987

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted